AI-driven detection identifies blood cancers using real-time imaging of blood samples, suggesting enhanced diagnostic aid for pathologists.
Early detection of blood cancers remains a critical challenge due to the limitations of conventional manual blood smear examinations, which are slow and dependent on expert interpretation. In response, this study presents an AI-driven approach that leverages the YOLO object detection framework paired with a standard webcam for real-time analysis of blood samples. Trained on a dataset of major blood cell types, the system demonstrates promising capability in distinguishing abnormal cells. By offering a cost-effective and accessible diagnostic aid, the method shows potential to support pathologists in the early screening of leukemia, lymphoma, myeloma, and related disorders.
No takes yet. Share an insight, caveat, or question.
Darshan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: